Dr. Hyams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
39000 Bob Hope Dr
Kiewit Building Suite 207
Rancho Mirage, CA 92270Phone+1 760-773-3311Fax+1 760-773-3811
Education & Training
George Washington UniversityResidency, Surgery, 1984 - 1986
National Cancer InstituteResidency, Nuclear Medicine, 1983 - 1984
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
University of California (San Francisco)Residency, Surgery, 1978 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1978
Certifications & Licensure
CA State Medical License 1980 - 2025
NY State Medical License 2010 - 2017
OH State Medical License 1988 - 2006
PA State Medical License 1994 - 2004
MD State Medical License 1982 - 1996- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Palm Springs Life Magazine Castle Connolly, 2007-2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Publications & Presentations
PubMed
- Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene exp...David M Hyams, Avital Bareket-Samish, Juan Enrique Bargallo Rocha, Sebastian Diaz-Botero, Sandra Franco
Journal of Surgical Oncology. 2024-08-01 - 2 citationsManagement of melanoma: can we use gene expression profiling to help guide treatment and surveillance?Jonathan S Zager, David M Hyams
Clinical & Experimental Metastasis. 2024-08-01 - 21 citationsIntegrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction.Eric D. Whitman, Vadim P. Koshenkov, Brian R. Gastman, Deri Lewis, Eddy C. Hsueh
JCO Precision Oncology. 2021-09-13
Press Mentions
Castle Biosciences Announces Publication of Peer-Reviewed Publication Demonstrating the Clinical Impact of DecisionDxDecember 4th, 2020
Castle Biosciences Presents Expanded Data Supporting Use of DecisionDx-Melanoma Test to Inform Sentinel Lymph Node Biopsy RecommendationsNovember 25th, 2019- Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual MeetingJune 4th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
